Cash Flow Statement

Altimmune (ALT) EBT Margin Growth (3y) (2013 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 48,476.00
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 441.00
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -408.00
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 7,297.00
10 Altimmune 379.61 Mn 379.61 Mn - -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 2.62 Mn
Sep 30, 2025 80.54 Mn
Jun 30, 2025 -19.13 Mn
Mar 31, 2025 -34.41 Mn
Dec 31, 2024 -46.34 Mn
Sep 30, 2024 -43.57 Mn
Jun 30, 2024 -47.47 Mn
Mar 31, 2024 -48.61 Mn
Dec 31, 2023 -2.36 Mn
Sep 30, 2023 -508,897.00
Jun 30, 2023 -26.92 Mn
Mar 31, 2023 -9.54 Mn
Dec 31, 2022 19.72 Mn
Sep 30, 2022 -118.39 Mn
Jun 30, 2022 -25.14 Mn
Mar 31, 2022 -6.10 Mn
Dec 31, 2021 89,188.00
Sep 30, 2021 -2.11 Mn
Jun 30, 2021 -1.77 Mn
Mar 31, 2021 -161,898.00
Dec 31, 2020 21,252.00
Sep 30, 2020 6,339.00
Jun 30, 2020 -25,524.00
Mar 31, 2020 120,615.00
Dec 31, 2019 -43,793.00
Sep 30, 2019 9.54 Mn
Jun 30, 2019 6,695.00
Mar 31, 2019 4,950.00
Dec 31, 2018 -95,956.00
Sep 30, 2018 -745.00
Jun 30, 2018 -23,735.00
Mar 31, 2018 -17,577.00
Dec 31, 2017 -53,334.00
Sep 30, 2017 -20,634.00
Jun 30, 2017 -12,291.00
Mar 31, 2017 -146,889.00
Dec 31, 2016 -15,277.00
Sep 30, 2016 -9.70 Mn
Jun 30, 2016 -24,672.00
Mar 31, 2016 -8,800.00
Dec 31, 2015 -7,556.00
Sep 30, 2015 -11,041.00
Jun 30, 2015 -19,095.00
Mar 31, 2015 6,212.00
Dec 31, 2014 -15,523.00
Sep 30, 2014 -47,766.00
Jun 30, 2014 2,573.00
Mar 31, 2014 -2,680.00
Dec 31, 2013 3,047.00
Sep 30, 2013 -4,326.00
Jun 30, 2013 10,655.00